Show
Sort by
-
- Journal Article
- A1
- open access
Factors associated with progression and outcomes of early stage primary biliary cholangitis
-
Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue-induced HBeAg seroconversion
-
Derivation of a machine learning model to predict clinical outcome in patients with primary biliary cholangitis
-
Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis
-
Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response
-
Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies
-
Alkaline phosphatase normalization is associated with a decreased risk for liver transplantation and death in patients with primary biliary cholangitis
-
Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis : risk factors and time trends in incidence and outcome
-
Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history
-
- Journal Article
- A1
- open access
Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment